ANTHONY DUSHANE: Open Payments
NPI 1487316121 · CASTLETON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,680 in 92 payments from 17 companies in 2025. Trend: 2023 $1,936 · 2024 $3,201 · 2025 $1,680
Food & beverage: $1,628Education: $52
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $430 |
| Novartis Pharmaceuticals Corporation | 13 | $215 |
| Janssen Biotech, Inc. | 7 | $161 |
| Incyte Corporation | 13 | $157 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
| GENZYME CORPORATION | 4 | $94 |
| UCB, Inc. | 3 | $85 |
| Galderma Laboratories, L.P. | 4 | $76 |
| Lilly USA, LLC | 4 | $72 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $68 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, OPZELURA, COSENTYX, Bimzelx, TALTZ, ILUMYA.
Industry payments across NY — which companies pay providers there.
